Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by JUNJI YONESE
Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma
Anticancer Research
Medicine
Cancer Research
Oncology
Related publications
Triplet Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin as Second-Line Therapy for Advanced Urothelial Carcinoma
Modern Chemotherapy
Gemcitabine and Cisplatin Neoadjuvant Chemotherapy for Muscle-Invasive Urothelial Carcinoma: Predicting Response and Assessing Outcomes
Urologic Oncology: Seminars and Original Investigations
Oncology
Urology
Gemcitabine Plus Vinorelbine as First-Line Chemotherapy in Advanced Nonsmall Cell Lung Carcinoma a Phase II Trial
Cancer
Cancer Research
Oncology
Phase II Study of Gemcitabine Plus Oxaliplatin as First-Line Chemotherapy for Advanced Non-Small-Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
A Phase II Study of Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Adenocarcinomas
British Journal of Cancer
Cancer Research
Oncology
Cisplatin-Based First-Line Therapy for Advanced Urothelial Carcinoma After Previous Perioperative Cisplatin-Based Therapy
Clinical Genitourinary Cancer
Oncology
Urology
Front-Line Treatment With Gemcitabine, Paclitaxel, and Doxorubicin for Patients With Unresectable or Metastatic Urothelial Cancer and Poor Renal Function: Final Results From a Phase II Study
Urology
Urology
Weekly Paclitaxel as Second-Line Chemotherapy for Advanced or Recurrent Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
A Phase I/Ii Study of Weekly Nab-Paclitaxel Plus Cisplatin in Chemotherapy-Naïve Patients With Advanced Non-Small-Cell Lung Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
